Pain During Injection With Botulinum Toxin in Post-stroke Spasticity Treatment
NCT ID: NCT03251521
Last Updated: 2017-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
46 participants
OBSERVATIONAL
2012-03-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of Ultrasound in Injections of Botulinum Toxin
NCT02566837
The Use of Ultrasound for Botulinum Toxin Subscapularis Muscle Injection Guidance in Spastic Hemiplegic Shoulder Pain
NCT03621423
HEMITOX : Effect of Botulinum Toxin Injections on Motor and Functional Ability of Upper Limb in Adults at Earlier Phases of Spastic Hemiplegia After Stroke
NCT00276185
Early Treatment of Post-stroke Spasticity With Botulinum Toxin
NCT04404868
Muscle Selection for Botulinum Toxin A Injection in Poststroke Elbow Flexor Spasticity
NCT04036981
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Particularly tracking by electrostimulation, but also skin puncture, toxin injection or needle withdrawal may be painful.
The objective of this study is to define an individual injection strategy in order to limit pain.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
spasticity post-stroke
pain rating during injection with botulinum toxin The pain intensity was rated verbally on a numeric scale
pain rating during injection with botulinum toxin
The pain intensity was rated verbally on a numeric scale. The pain was rated after each phase of injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pain rating during injection with botulinum toxin
The pain intensity was rated verbally on a numeric scale. The pain was rated after each phase of injection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* severe upper or lower limb spasticity (Ashworth score ≥ 2 for at least one muscle)
* patients requiring a treatment by botulinum toxin
* patients refusing analgesia for injections.
Exclusion Criteria
* cognitive impairment or psychiatric disease altering the reliability of pain evaluation
* patient medically unstable.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dominic PERENNOU, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Grenoble
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
38RC17.251
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.